T-cell maturation
Studied in relation to thymocyte differentiation and T-lymphocyte function.
These are results measured on this lot. Full material specification is in Know your compound.
Immune Peptide
A 28-residue thymic peptide studied in immune-modulation research.
$42.50 per vial with BOGO
Research use only — not for human or veterinary use, diagnostic or therapeutic.
Know your compound
Thymosin alpha-1 is a 28-amino-acid acetylated peptide originally isolated from thymic tissue, the organ where T lymphocytes mature. It is a distinct molecule from thymosin beta-4 (the parent of TB-500) — the shared "thymosin" name reflects the tissue they were isolated from, not a structural relationship.
Published research examines the peptide in relation to T-cell maturation and innate immune signalling, particularly Toll-like receptor pathways in dendritic cells. It has one of the longer clinical research records of any peptide in this catalog, largely in infectious-disease and immunology settings — that literature describes studied populations, not this material.
Supplied as a lyophilized powder for laboratory research use only, with a lot-specific Certificate of Analysis. Nothing here describes an approved therapy or a use in humans.
Read left to right from the N-terminus. Mass spectrometry checks each lot against this sequence — that result is the “Identity” line on the certificate.
What the molecule is.
How we know the material matches the label.
What arrives, and how it is kept.
What the literature examines
Summaries of what published research has investigated. Preclinical unless stated otherwise — not claims about this product.
Studied in relation to thymocyte differentiation and T-lymphocyte function.
Published work examines TLR-mediated pathways in dendritic cells and innate immune activation.
Structurally unrelated to TB-500 despite the shared thymic naming.
Certificate of Analysis
Not a brand-wide spec sheet — a lot-specific certificate from an independent laboratory, published before the lot ships and searchable by lot number forever.
Independent U.S. laboratory
Certificate of Analysis · RFX-2606-080
| Test | Specification | Result |
|---|---|---|
| Purity (HPLC) | ≥ 99.0% | 99.4% |
| Identity (LC-MS) | Conforms | Conforms |
| Appearance | White powder | Conforms |
| Net content | Label claim | Conforms |
Questions
No. Thymosin Alpha-1 is not an FDA-approved drug and is not approved for human or veterinary use. It is supplied exclusively as a research material for laboratory use, and it is not intended to diagnose, treat, cure, or prevent any disease.
Yes. Every lot is assayed by an independent U.S. laboratory for purity and identity, and the certificate for the lot you receive is published in our COA library — you can read it before you order.
Purity is quantified by reverse-phase HPLC against a reference standard, and identity is confirmed by mass spectrometry. Both results appear on the lot certificate.
Lyophilized material is typically stored cold and protected from light. Handling and storage are the responsibility of the receiving laboratory; refer to the lot documentation for specifics.
Every second vial is free, sitewide and automatically. Add two vials and you pay for one; add six and you pay for three. Compounds can be mixed, there is no code, and there is no limit.
Orders are processed promptly and shipped with tracking. Free US shipping applies over $100; Priority shipping is $8.95 otherwise.
The guarantee
Have any lot independently re-tested. If the results don't match the purity printed on its published certificate, we refund the order in full — no returns, no argument.
Same research area